Research Article

Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study

Volume: 43 Number: 3 September 30, 2021
EN

Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study

Abstract

Objective: International studies have shown that overall sexual activity and frequency of sexual intercourse decreased significantly during the COVID-19 pandemic. The aim of this study is to compare the female sexual dysfunction (FSD) rate in women during the COVID-19 pandemic in tertiary hospital in Turkey.
Method: A total of 150 participants who were 50 pregnant women (group I), 50 healthcare women (group II) and 50 other women (group III), participated in study. A female sexual function index (FSFI) questionnaire was applied to the women along with the questions of age, education level, delivery methods, smoking, employment status and socioeconomic levels. The sexual dysfunction rate and female sexual function index scores between the groups were compared.
Results: The median FSFI score was 23.50 in the present study population. Median scores were 22.1, 26.5, and 23.1 for groups I (pregnant), II (healthcare workers) and III (others), respectively. When the FSFI scores of the groups were compared, the FSFI score of group II was statistically significantly higher than the other groups (p: 0,001). By using the cutoff FSFI score of 26.55, 68.7 % (n:103) of women were diagnosed as having sexual dysfunction. The rates of sexual dysfunction as follows 84%, 52%, and 70% for groups I, II and III, respectively. When analyzed with FSFI domains one by one, it was seen that Group 2 had a statistically significantly higher FSFI score in the areas of Arousal, Lubrication, Orgasm, and Pain compared to the other groups.
Conclusions: The prevalence of FSD in Turkey increased during COVID-19 pandemic. When comparing female sexual dysfunction prevalence in groups, the lowest sexual dysfunction prevalence was found in healthcare workers. Prevalence of sexual dysfunction was found to be associated with women's employment and educational status.

Keywords

References

  1. 1) Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020; 16(6):1232 1238.
  2. 2) Kazan Kizilkurt O, Dilbaz N, Noyan CO. Psychological Impact of COVID-19 Pandemic on General Population in Turkey: Risk Factors. Asia Pac J Public Health. 2020 ;32(8):519
  3. 3) American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1): e1-e18.
  4. 4) Reddy RM, Saravanan RA, Praharaj SK, Thirunavukarasu M. Sexual Dysfunction in Women with Depression: A Hospital-Based Cross-sectional Comparative Study. Indian J Psychol Med. 2020 6;42(1):46-51.
  5. 5) Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970–8. (Level II-3)
  6. 6) Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175(2):654-8; discussion 658.
  7. 7) Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72(1):52-7.
  8. 8) Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther.2000; 26: 191-208.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

September 30, 2021

Submission Date

July 23, 2021

Acceptance Date

August 20, 2021

Published in Issue

Year 2021 Volume: 43 Number: 3

APA
Küçükyıldız, İ. (2021). Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study. Cumhuriyet Medical Journal, 43(3), 241-248. https://doi.org/10.7197/cmj.973939
AMA
1.Küçükyıldız İ. Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study. CMJ. 2021;43(3):241-248. doi:10.7197/cmj.973939
Chicago
Küçükyıldız, İrem. 2021. “Sexual Dysfunction in Women During COVID-19 Pandemic: A Hospital-Based, Prospective, Cross-Sectional Comparative Study”. Cumhuriyet Medical Journal 43 (3): 241-48. https://doi.org/10.7197/cmj.973939.
EndNote
Küçükyıldız İ (September 1, 2021) Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study. Cumhuriyet Medical Journal 43 3 241–248.
IEEE
[1]İ. Küçükyıldız, “Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study”, CMJ, vol. 43, no. 3, pp. 241–248, Sept. 2021, doi: 10.7197/cmj.973939.
ISNAD
Küçükyıldız, İrem. “Sexual Dysfunction in Women During COVID-19 Pandemic: A Hospital-Based, Prospective, Cross-Sectional Comparative Study”. Cumhuriyet Medical Journal 43/3 (September 1, 2021): 241-248. https://doi.org/10.7197/cmj.973939.
JAMA
1.Küçükyıldız İ. Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study. CMJ. 2021;43:241–248.
MLA
Küçükyıldız, İrem. “Sexual Dysfunction in Women During COVID-19 Pandemic: A Hospital-Based, Prospective, Cross-Sectional Comparative Study”. Cumhuriyet Medical Journal, vol. 43, no. 3, Sept. 2021, pp. 241-8, doi:10.7197/cmj.973939.
Vancouver
1.İrem Küçükyıldız. Sexual dysfunction in women during COVID-19 pandemic: A hospital-based, prospective, cross-sectional comparative study. CMJ. 2021 Sep. 1;43(3):241-8. doi:10.7197/cmj.973939

Cited By